- Home
- Case Studies
- Videos
- Webinars
Featured Webinars
Should your next clinical trial use a new supply model?
Understanding the key characteristics and use cases of static vs. dynamic supply models
Optimized Antibody Drug Conjugate Development
How can new technology platforms optimize Antibody Drug Conjugate Design?
Featured Case Studies
OptiForm® Solution Suite Accelerates Bioavailability Enhancement for Early Phase Molecule
Formulation Development With Minimal Amount Of API
-
Case Study: OptiForm® Solution Suite Accelerates Bioavailability Enhancement for Early Phase Molecule
-
Versatility Of Softgel Technology
-
GPEx® To Increase Production Of Pritumumab
-
Determination Of API Crystalline State
-
Formulation Development With Minimal Amount Of API
-
OptiForm® Solution Suite | Catalent in 90 Seconds
-
Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds
-
Global Advantage | Free Trade Zones in China
-
OptiGel™ Bio Technology | Catalent in 90 Seconds
-
Comparator and Marketed Drug Sourcing Solutions | Catalent in 90 Seconds
-
Optimal Drug Delivery Technologies. Better Treatments
-
Improving Bioavailability with Softgel Technology
-
Behind the Scenes: Catalent IPO on the NYSE
-
About Catalent: More Products. Better Treatments. Reliably Supplied
-
Should your next clinical trial use a new supply model?
-
The Challenges and Solutions for Non-invasive Macromolecule Delivery
-
Clinical trial supply strategies for biosimilar studies
-
Highly Potent API Handling from Optimization through Supply
-
Optimized Antibody Drug Conjugate Development
-
Optimizing API Bioavailability and Performance using Particle Size Reduction Technologies
- @catalentpharma